Target- |
MechanismT lymphocyte replacements |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismCell replacements |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Advanced Gene & Cell Technologies OOO
0 Patents (Medical) associated with Advanced Gene & Cell Technologies OOO
100 Deals associated with Advanced Gene & Cell Technologies OOO
100 Translational Medicine associated with Advanced Gene & Cell Technologies OOO